ZVRA
Zevra Therapeutics, Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||
| Capital Expenditures | 835,000 | 0 | 296,000 | 93,000 | 102,000 | 33,000 | 26,000 | 21,000 | 181,000 | 643,000 | 135,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||
| Free Cash Flow | -2.4M | -69.7M | -33.8M | -18.8M | 10.3M | -2.0M | -23.8M | -54.2M | -33.3M | -30.4M | -20.4M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — |